Neuropharmacology and Psychopharmacology

Neuropharmacology and Psychopharmacology explore the effects of drugs on the nervous system and mental health. This track will cover the mechanisms of action of neuroactive drugs, treatment of neurological and psychiatric disorders, and the development of novel therapeutics targeting the brain. Topics include neurotransmitter systems, neurodegenerative diseases, mood disorders, and addiction. The session aims to highlight advances in CNS drug research and the role of pharmacology in improving mental and neurological health outcomes.

 

    Related Conference of Neuropharmacology and Psychopharmacology

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Neuropharmacology and Psychopharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in